Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonel Trebicka

Showing results (31-40 of 511) with videos related to

Pageof 52
Sort By:
Hepatology (Baltimore, Md.)|March 14, 2014
Reply: To PMID 24259407Len Verbeke, Jonel Trebicka, Wim Laleman
Hepatology (Baltimore, Md.)|August 18, 2016
Evolving insights in the pathophysiology of complications of cirrhosis: The farnesoid X receptor (FXR) to the rescue?Wim Laleman, Jonel Trebicka, Len Verbeke
Journal of Hepatology|December 6, 2020
Reply to: Correspondence on 'The PREDICT study uncovers three clinical courses of acutely decompensated cirrhosis that have distinct pathophysiology'Jonel Trebicka, Javier Fernandez, Vicente Arroyo, et al.
Visceral Medicine|October 23, 2018
Gut-Liver Axis Links Portal Hypertension to Acute-on-Chronic Liver FailureJonel Trebicka, Thomas Reiberger, Wim Laleman
Zeitschrift Fur Gastroenterologie|January 18, 2022
Review series on Pathophysiology and Clinical Management of Alcoholic Liver DiseaseSteven Dooley, Jonel Trebicka, Sebastian Mueller
Deutsche Medizinische Wochenschrift (1946)|August 30, 2017
[Statins as a Therapy of Chronic Liver Disease?]Tilman Sauerbruch, Robert Schierwagen, Jonel Trebicka
Clinical Liver Disease|June 6, 2022
Transplantation in Acute-on-Chronic Liver Failure: Feasibility and FutilityAlexander Queck, Nina Weiler, Jonel Trebicka
F1000Research|May 22, 2018
Managing portal hypertension in patients with liver cirrhosisTilman Sauerbruch, Robert Schierwagen, Jonel Trebicka
Seminars in Liver Disease|May 16, 2023
Endoscopic Advances in HepatologyEmma Vanderschueren, Jonel Trebicka, Wim Laleman
Cellular and Molecular Gastroenterology and Hepatology|August 1, 2020
A New Treatment for Chronic Hepatitis B and D Offers Novel Insights Into Obesity and Hepatic SteatosisRobert Schierwagen, Sabine Klein, Jonel Trebicka
Pageof 52

Showing results (31-40 of 511) with videos related to

Sort By:
Pageof 52
Hepatology (Baltimore, Md.)|March 14, 2014
Reply: To PMID 24259407Len Verbeke, Jonel Trebicka, Wim Laleman
Hepatology (Baltimore, Md.)|August 18, 2016
Evolving insights in the pathophysiology of complications of cirrhosis: The farnesoid X receptor (FXR) to the rescue?Wim Laleman, Jonel Trebicka, Len Verbeke
Journal of Hepatology|December 6, 2020
Reply to: Correspondence on 'The PREDICT study uncovers three clinical courses of acutely decompensated cirrhosis that have distinct pathophysiology'Jonel Trebicka, Javier Fernandez, Vicente Arroyo, et al.
Visceral Medicine|October 23, 2018
Gut-Liver Axis Links Portal Hypertension to Acute-on-Chronic Liver FailureJonel Trebicka, Thomas Reiberger, Wim Laleman
Zeitschrift Fur Gastroenterologie|January 18, 2022
Review series on Pathophysiology and Clinical Management of Alcoholic Liver DiseaseSteven Dooley, Jonel Trebicka, Sebastian Mueller
Deutsche Medizinische Wochenschrift (1946)|August 30, 2017
[Statins as a Therapy of Chronic Liver Disease?]Tilman Sauerbruch, Robert Schierwagen, Jonel Trebicka
Clinical Liver Disease|June 6, 2022
Transplantation in Acute-on-Chronic Liver Failure: Feasibility and FutilityAlexander Queck, Nina Weiler, Jonel Trebicka
F1000Research|May 22, 2018
Managing portal hypertension in patients with liver cirrhosisTilman Sauerbruch, Robert Schierwagen, Jonel Trebicka
Seminars in Liver Disease|May 16, 2023
Endoscopic Advances in HepatologyEmma Vanderschueren, Jonel Trebicka, Wim Laleman
Cellular and Molecular Gastroenterology and Hepatology|August 1, 2020
A New Treatment for Chronic Hepatitis B and D Offers Novel Insights Into Obesity and Hepatic SteatosisRobert Schierwagen, Sabine Klein, Jonel Trebicka
Pageof 52